Therapeutic targets in bronchial asthma pathophysiology

Pediatric Asthma, Allergy and Immunology

Volumn 12, Issue 4, 1998, Pages 241-251

  Galant, Stanley P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; MONOCLONAL ANTIBODY; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; TRYPTASE;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; EOSINOPHIL; EPITHELIUM CELL; HUMAN; INFLAMMATION; MACROPHAGE; MAST CELL; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032458544     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.1998.12.241     Document Type: Article

References (36)

1. Guidelines for the diagnosis and management of asthma. Expert Panel Report #2, April 1997. NIH publication 97-4051.
2. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-703.
3. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
4. Robinson DS, Hamid Q, Ying A, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.
5. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;32:863-875.
6. Redington AE, Howarth PH. Airway wall remodeling in asthma. Thorax 1997;52:310-312.
7. Busse WW, Calhoun WF, Sedgwick JD. Mechanism of airway inflammation in asthma. Am Rev Respir Dis 1993;147:S20-S24.
8. Fushimo T, Okayama H, Shimura S, et al. Dexamethasone suppresses expression and production of IL13 by human mast cell, line and lung mast cells. J Allergy Clin Immunol 1998;102:134-142.
9. Molinan JF, Scuri M, Moore WR, et al. Inhaled tryptase causes bronchoconstriction in sheep via histamine release. Am J Respir Crit Care Med 1996;154:649-653.
10. Clark JM, Abraham WM, Fishman CE. Tryptase inhibitors block allergen induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995;152:276-283.
11. Wegner CD, Gundall RH, Riley P, et al. Intercellular adhesion molecule-1 (ICAM-1) in pathogenesis of asthma. Science 1990;247:456-460.
12. Maurer PJ, Pittman AM, Fernandez X, et al. Effects of an antibody to IL5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:467-472.
13. Rajakulasingam K, Til S, Ying S. Increased expression of high affinity IgE receptor alpha chain and mRNA in protein bearing eosinophils in human allergen induced atopic asthma. Am J Respir Crit Care Med 1998;158:233-240.
14. Busse W, Kaufman RL, Gelfand W, et al. Mechanisms of persistent airway inflammation and asthma: A role for T-cell and T-cell products. Am J Respir Crit Care Med 1995;152:388-393.
15. Hogan SP, Matthaei KI, Young JN. A novel T-cell regulated mechanism modulating allergen induced airway hyper-reactivity in BALB/C mice independently of IL4 and IL5. J Immunol 1998;168:1501-1509.
16. Maurer D, Fieberger E, Reininger B, et al. Expression of high affinity immunoglobulin E receptors on monocytes of atopic individual. J Exp Med 1994;179:745-750.
17. Levine SJ. Bronchial epithelial cell-cytokine interaction in airway epithelium. J Investig Med 1995;43:241-249.
18. Jirapongsananaruk O, Leung DYM. Clinical applications of cytokines: New directions in the therapy of atopic diseases. Ann Allergy Asthma Immunol 1997;79:5-20.
19. Douglas W, Henry PJ. Endothelin-1, a mediator in asthma? Am J Respir Crit Care Med 1996;154:1594-1598.
20. Zuany-Amoran C, Haile S, Leduc D. Interleukin 10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995;95:2644-2651.
21. Iwamoto I, Kotaro K, Kosai M. Interleukin 12 prevents antigen induced eosinophil recruitment into mouse airways. Am J Respir Crit Care Med 1996;154:1257-1260.
22. McDyer JF, Woo CY, Seder RA. The regulation of IL12: Its role in infection, autoimmune and allergic diseases. J Allergy Clin Immunol 1998;102:11-15.
23. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
24. Passalacqua G, Ciprandi G, Bagnasco M. et al. Adhesion molecules in allergy - recent insights. Allergy & Clinical Immunology International 1998;10:23-29.
25. Barnes PJ, Baraniuk JN, Belvis MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991;144:1187-1198, 1391-1399.
26. Torphy TJ. Phosphodiesterase isoenzymes. Molecular targets for novel anti-asthma agents. Am J Respir Crit Care Med 1998;157:351-370.
27. Haley KJ, Drazen JM. Inflammation and airway function in asthma [Editorial]. Am J Respir Crit Care Med 1998;157:1-3.
28. Walker C, Bodie E, Baer L, et al. Allergic and non-allergic asthmatics have distinct patterns of T-cell activation in cytokine production and peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-115.
29. Humbert M, Durham SR, Ying S, et al. IL4 and IL5 mRNA and protein in bronchial biopsies from patients with atopic and non-atopic asthma: Evidence against "intrinsic asthma" being a distinct immuno-pathologic entity. Am J Respir Crit Care Med 1996;154:1497-1504.
30. Hogan SP, Mould A, Kikutane H, et al. Aeroallergen induced eosinophilic inflammation, lung damage and hyper responsiveness in mice can occur independently of IL4 allergen specific immunoglobulins. J Clin Invest 1997;99:1329-1339.
31. Corry DB, Folkesson HG, Warnock ML, et al. Interleukin 4 but not interleukin 5 or eosinophils is required in a murine model of acute airway hypersensitivity. J Exp Med 1996;183:109-117.
32. Hammelmann E, Gelfand W. The role of cytokines and the development of allergen induced airway hyper responsiveness. Allergy & Clinical Immunology International 1998;10:59-64.
33. Pascal D, Bousquet J. Anti-IgE therapy for asthma. Am J Respir Crit Care Med 1997;155:1825-1827.
34. Kung TT, Stelts DM, Zurcher JA, et al. Involvement of IL5 in a murine model of allergic pulmonary inflammation: Prophylactic and therapeutic effects of an anti-IL5 antibody. Am J Respir Cell Mol Biol 1995;13:360-365.
35. Renz H, Bradley K, Enssle K, et al. Prevention of the development of immediate hypersensitivity and airway hyper responsiveness following in vivo treatment with soluble IL4 receptor. Int Arch Allergy Immunol 1996;109:167-176.
36. Kon OM, Sihra B, Compton CH, et al. Randomized dose-ranging, placebo-controlled study of chimeric antibody to CD4 in chronic severe asthma. Lancet 1998;352:1109-1113.